Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D Imaging Drug Design Solutions (3DIDDS) is a biotechnology company focused on accelerating drug discovery through advanced 3D imaging and computational modeling. The company utilizes a proprietary platform that integrates high-resolution structural biology with artificial intelligence to design highly specific small molecule therapeutics. By visualizing drug-target interactions at the atomic level, 3DIDDS aims to reduce the time and cost associated with traditional lead optimization. Their current research efforts are primarily directed toward oncology and central nervous system disorders, where precise molecular targeting is critical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3D Imaging Drug.